Isis Pharmaceuticals

Listing Websites about Isis Pharmaceuticals

Filter Type:

Home - Isispharma

(Just Now) IsisPharma uses cookies to measure the audience of the site and the content offered. IsisPharma also relies on third party services that store cookies in your terminal to enable you to interact on social networks and view videos directly on the site.

Isispharma.com

Category:  Health Detail Drugs


ISIS Pharmaceuticals (ISIS) - Forbes

(4 days ago) Isis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and cardiovascular and

Forbes.com

Category:  Pharmaceutical,  Health Detail Drugs


ISIS: Ionis Pharmaceuticals Inc Stock Price Quote - Bloomberg

(9 days ago) Stock analysis for Ionis Pharmaceuticals Inc (ISIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals, Inc. LinkedIn

(8 days ago) Isis Pharmaceuticals, Inc. is a pharmaceuticals company based out of 2855 Gazelle Court, Carlsbad, California, United States.

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals - Yahoo! News

(3 days ago) Isis Pharmaceuticals tumbled 21.9% to 10.27 over questions of possible cancer links with its experimental cholesterol drug Kynamro.An FDA advisory panel noted that 3.1% of those in clinical trials developed benign and cancerous tumors vs. 0.9% in the control group, raising doubts the drug will win approval.

News.yahoo.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals

(7 days ago) CARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its name to Ionis Pharmaceuticals, Inc. Ionis (pronounced "eye-OH-nis") Pharmaceuticals is an original name that the Company has chosen to represent its innovative culture and heritage as both the pioneer and leader in the RNA …

Ir.ionispharma.com

Category:  Pharmaceutical Detail Drugs


Home Ionis Pharmaceuticals, Inc.

(8 days ago) Transformative technology. We are the leader in discovering and developing RNA-targeted therapeutics. Our efficient, broadly applicable drug discovery platform, called antisense technology, can treat illnesses where no other therapeutic approaches have proven effective or ever existed. Learn more about our Ionis Innovations.

Ionispharma.com

Category:  Health Detail Drugs


Isis pharmaceuticals sustanon 250, dmz half-life USC

(Just Now) Isis pharmaceuticals sustanon 250, cheap buy legal steroid bodybuilding drugs. This is because of its high cost due to its expense, but the medical benefits of this drug also make it highly recommended. Sustanon 250 is a muscle-reducing, testosterone booster and is very similar to Dianabol in that regard. Sustanon 250 is a synthetic form of

Games.usc.edu

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals to change its name Ionis Pharmaceuticals

(8 days ago) Isis Pharmaceuticals on Friday announced that it will change its name to Ionis Pharmaceuticals.. The company's shares, which now trade on the Nasdaq under the ticker "ISIS," will trade under the

Cnbc.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals

(4 days ago) Ionis Pharmaceuticals. CARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its name to Ionis Pharmaceuticals, Inc

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


3 Things to Watch at Isis Pharmaceuticals

(Just Now) Isis Pharmaceuticals hit rough waters with its lead drug, Kynamro. But the small-cap developer of antisense drugs has a populated pipeline and a wide range of big pharma partners. If the Food and Drug Administration denies Kynamro, will the

News.yahoo.com

Category:  Pharmaceutical Detail Drugs


Technology evaluation: fomivirsen, Isis Pharmaceuticals

(1 days ago) Fomivirsen (ISIS-2922, Vitravene) is an antisense 21 mer phosphorothioate oligonucleotide with sequence complementarity to the coding region of the major immediate-early gene of human cytomegalovirus (CMV). Developed by Isis Pharmaceuticals Inc, fomivirsen is the first antisense oligonucleotide to r …

Pubmed.ncbi.nlm.nih.gov

Category:  Pharmaceutical Detail Drugs


ISIS Pharmaceuticals & Chemicals Works Products - Sehat

(Just Now) Pakistan’s Premier Online Pharmacy delivering medicines nationwide, with multiple payment options such as credit card payment, Easy Paisa, and Internet banking

Sehat.com.pk

Category:  Pharmacy Detail Drugs


Isis Pharmaceuticals, Inc. 301012 Does Not Interact With

(8 days ago) about isis pharmaceuticals, inc. Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 12 antisense drugs in development to treat cardiovascular, metabolic, inflammatory and ocular diseases

Biospace.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Inc - News, Articles etc. - European

(4 days ago) Isis Pharmaceuticals initiates Phase 2 study of ISIS-FXI Rx in ESRD. 30 October 2015 By Victoria White. The Phase 2 study is intended to further characterise the profile of ISIS-FXI Rx and will provide essential data for Bayer's future clinical development programme for …

Europeanpharmaceuticalreview.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals 2855 Gazelle Ct Carlsbad, CA

(9 days ago) Isis Pharmaceuticals is a biopharmaceutical company that researches and develops therapeutic drugs for conditions, including inflammatory, metabolic, and cardiovascular diseases, and cancer. Founded in 1989, Isis owns more than 1,500 issued patents worldwide, and discovers and develops ribonucleic acid-based drugs.

Mapquest.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Isis Pharma deal brings $100M upfront - San Diego Union

(5 days ago) Isis Pharma deal brings $100M upfront Dr. Sanjay Bhanot, a vice president at Isis Pharmaceuticals, is overseeing clinical trials to develop the drug ISIS-FX to treat blood clots. / photo by Peggy

Sandiegouniontribune.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Reports Encouraging Data on ISIS

(1 days ago) CARLSBAD, Calif., June 3, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that data from the Phase 1 study of ISIS-STAT3 Rx in patients with cancer were presented today at

Prnewswire.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Isis Pharma Changes Its Name To Free Execs And Investors

(8 days ago) Isis Pharmaceuticals CEO Stanley Crooke really didn't want to change the name of the company he founded a quarter of a century ago. He explains his change of heart.

Forbes.com

Category:  Pharmaceutical,  Heart Detail Drugs


ISIS Pharmaceuticals & Chemical Works LinkedIn

(4 days ago) ISIS Pharmaceuticals & Chemical Works 390 followers on LinkedIn. Quality Trusted by Generations ISIS Pharmaceuticals & Chemical Works is one of the leading Producers of Allopathic Drugs, Veterinary Medicines and Herbal/Nutraceutical Products in Pakistan, located in Karachi which is the financial hub of the country. We are an ISO certified company, following …

Pk.linkedin.com

Category:  Pharmaceutical Detail Drugs


Working at Ionis Pharmaceuticals: Employee Reviews

(6 days ago) Isis' policy was to teach/train/promote each employee to her/his highest capability. My position was created from the need to claim the next corporate step of submitting an NDA for Isis' first drug. We all were on a steep learning curve learning exactly what the FDA required to permit a drug to go market.

Indeed.com

Category:  Health Detail Drugs


Isis Pharmaceuticals, Inc. SWOT Analysis - Boston

(8 days ago) The item Isis Pharmaceuticals, Inc. SWOT Analysis represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Boston University Libraries. This item is available to borrow from all library branches.

Link.bu.edu

Category:  Pharmaceutical Detail Drugs


449551 (ISIS) Stock Price, News, Quote & History - Yahoo

(6 days ago) Find the latest 449551 (ISIS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com

Category:  Health Detail Drugs


IONIS PHARMACEUTICALS, INC.

(7 days ago) IONIS PHARMACEUTICALS, INC. ISIS 396443-CS3A . A Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Nusinersen (ISIS 396443) Delivered Intrathecally to Patients with Infantile-Onset Spinal Muscular Atrophy . Protocol Amendment 6 – 25 January 2016 . Sponsor: Ionis Pharmaceuticals, Inc. 2855 Gazelle Court

Clinicaltrials.gov

Category:  Pharmaceutical Detail Drugs


ISIS PHARMACEUTICALS PRIVATE LIMITED - Company, directors

(2 days ago) Isis Pharmaceuticals Private Limited is a Private incorporated on 10 May 2002. It is classified as Non-govt company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs. 100,000 and its paid up capital is Rs. 100,000.

Zaubacorp.com

Category:  Pharmaceutical Detail Drugs


Isis Pharma changes its name to not be confused with

(6 days ago) Isis Pharma is going a step further than diet candy Ayds, which was forced to rebrand itself in the 1980s when the AIDS epidemic was raging. But the candy name was merely tweaked to Diet Ayds.

Money.cnn.com

Category:  Health Detail Drugs


Technology evaluation: ISIS-104838, OraSense

(1 days ago) OraSense Ltd (a joint venture between Isis Pharmaceuticals Inc and Elan Corp) is developing ISIS-104838, an antisense oligonucleotide specific for TNF alpha mRNA, as an inhibitor of TNF alpha synthesis. The compound is being developed for the potential treatment of inflammatory diseases such as rheu …

Pubmed.ncbi.nlm.nih.gov

Category:  Pharmaceutical Detail Drugs


IONIS PHARMACEUTICALS, INC.

(7 days ago) IONIS PHARMACEUTICALS, INC. ISIS 505358-CS3 . A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Escalation Study to Examine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ISIS 505358 in Treatment-Nave Patients with Chronic Hepatitis B Virus Infection . Protocol Amendment 1 – 19 February 2016 . Sponsor:

Clinicaltrials.gov

Category:  Pharmaceutical Detail Drugs


Ionis Pharmaceuticals, Inc. (IONS) Stock Price, News

(6 days ago) Ionis Pharmaceuticals, Inc. Analyst Report: Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals

(4 days ago) Company's Shares Will Trade Under New Ticker Symbol IONS CARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its

Fiercepharma.com

Category:  Pharmaceutical Detail Drugs


Ionis Pharmaceuticals, Inc. (IONS) Stock Price Today

(6 days ago) View as data table, Ionis Pharmaceuticals, Inc. price and volume. The chart has 1 X axis displaying Time. Range: 2021-01-19 16:00:00 to 2022-01-22 07:21:36. The chart has 2 Y axes displaying

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals, Inc. Adds Two New Drugs to

(1 days ago) CARLSBAD, Calif., Jan. 6, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that it has added two new drugs to its development pipeline, ISIS-FGFR4Rx and ISIS-STAT3Rx. ISIS-FGFR4Rx is designed to treat obesity by increasing metabolism, particularly by increasing lipid and fat burning. ISIS-FGFR4Rx specifically blocks …

Biospace.com

Category:  Pharmaceutical Detail Drugs


Ionis Pharmaceuticals, Inc. Company Information Drugs.com

(8 days ago) Ionis Pharmaceuticals, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on …

Drugs.com

Category:  Medications,  Pharmaceutical Detail Drugs


Amazon.com: Isis Pharma Neotone Pigmentation Spots - Serum

(5 days ago) Choose items to buy together. This item: Isis Pharma Neotone Pigmentation Spots - Serum. $35.00 ($34.31/Fl Oz) In Stock. Sold by BFStayClose and ships from Amazon Fulfillment. FREE Shipping. ISIS pharma Day Care NEOTONE radiance SPF 50+ Protective revealing cream 30ml WE GOOD SKIN. $37.00 ($37.00/Fl Oz) In Stock.

Amazon.com

Category:  Health Detail Drugs


Ionis Pharmaceuticals Corporate Headquarters - DPR

(2 days ago) Ionis Pharmaceuticals Corporate Headquarters Carlsbad, California. Several years and many projects after DPR constructed one of its first projects in the region for Ionis Pharmaceuticals, Inc., the San Diego office came full circle by completing this ground-up 175,000-sq.-ft., state-of-the-art research facility.

Dpr.com

Category:  Pharmaceutical Detail Drugs


Highest Paying Jobs at Isis Pharmaceuticals - Find

(8 days ago) Find 10 available jobs at Isis Pharmaceuticals with Ladders. Join Ladders to find the latest jobs at Isis Pharmaceuticals and get noticed by over 90,000 recruiters.

Theladders.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals, Inc. - a Carlsbad, California (CA

(Just Now) Isis Pharmaceuticals, Inc., a Carlsbad, California (CA) Law Firm - Consider the following: Comfort Level - Are you comfortable telling the lawyer personal information?

Lawyers.findlaw.com

Category:  Pharmaceutical Detail Drugs


Isis Pharma changes name to Ionis Pharma - The San Diego

(2 days ago) Isis Pharmaceuticals has changed its name to Ionis Pharmaceuticals, the Carlsbad biotech company announced Friday. With the new name -- free of any similarities to the widely used acronym for the

Sandiegouniontribune.com

Category:  Pharmaceutical Detail Drugs


Amazon.com: ISIS Pharma RUBORIL METRORUBORIL A.Z. Anti

(3 days ago) Ships from and sold by DealonUS. $28.40 shipping. Isis Pharma Ruboril Expert Spf 50 Anti Redness Cream 40Ml. $19.70 ($14.49/Fl Oz) Only 1 left in stock - order soon. Sold by BFStayClose and ships from Amazon Fulfillment. FREE Shipping on orders over $25.00.

Amazon.com

Category:  Health Detail Drugs


Ionis Pipeline: Antisense Drugs for a Broad Range of Diseases

(4 days ago) Chemistry: Generation 2 + LICA. Pelacarsen, also known as IONIS-APO(a)-L Rx , AKCEA-APO(a)-L Rx , and TQJ230, is an investigational antisense medicine designed to reduce apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a), or Lp(a), a very atherogenic and thrombogenic form of LDL.Elevated Lp(a) is recognized as an independent, …

Ionispharma.com

Category:  Health Detail Drugs


Isis Pharma considers name change after Paris attacks

(Just Now) Isis Pharmaceuticals is tired of sharing a name with the terrorist group that carried out horrific acts of violence in Paris last week. The California biotech company is named after an Egyptian

Money.cnn.com

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals High Paying Jobs, Compensation

(1 days ago) High-Paying Jobs at Isis Pharmaceuticals. Director, In-house Patent Attorney, Biochemistry or Molecular/Cellular Biology. $200K — $250K *. Isis Pharmaceuticals • Carlsbad, CA …

Theladders.com

Category:  Pharmaceutical Detail Drugs


PRESS RELEASE: Archemix and Isis Pharmaceuticals Form

(6 days ago) About Isis Pharmaceuticals, Inc. Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for …

Fiercebiotech.com

Category:  Pharmaceutical Detail Drugs


ISIS Pharmaceuticals Has The Cash To Develop Its Expanding

(6 days ago) ISIS Pharmaceuticals has made a strong start to 2015, with $27 million in milestone payments already. In 2014, the company beat its own cash projections by $150 million.

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Stanley Crooke - Isis Pharmaceuticals Inc (isis) - The

(5 days ago) Dr. STANLEY T. CROOKE is Founder, Chairman and Chief Executive Officer of Isis Pharmaceuticals, Inc. Isis is a development stage biopharmaceutical company that is focused on a new paradigm in drug

Twst.com

Category:  Pharmaceutical Detail Drugs


All Eyes on ISIS Pharmaceuticals, Inc.'s Pipeline The

(1 days ago) Isis Pharmaceuticals (NASDAQ:IONS) releases earnings on Friday, but don't expect the company to give investors much information about …

Fool.com

Category:  Pharmaceutical Detail Drugs

Filter Type: